Skip to main content

Institutional intelligence for Mankind Pharma Ltd

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters72.63%
  • FII9.45%
  • Mutual Funds10.87%
  • DII (ex-MF)4.52%
  • Retail & others2.53%
  • 1% Club 6.40%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

72.63%9 named
HolderStakeSharesValue (₹ Cr)
20.18%8,33,52,652₹20.76k Cr
19.35%7,99,30,520₹19.91k Cr
14.95%6,17,55,635₹15.38k Cr
4.67%1,92,77,647₹4.80k Cr
2.79%1,15,33,906₹2.87k Cr
2.56%1,05,57,626₹2.63k Cr
1.97%81,54,463₹2.03k Cr
1.66%68,55,990₹1.71k Cr
1.57%65,00,021₹1.62k Cr

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

6.40%3 named
HolderStakeSharesValue (₹ Cr)
2.77%1,14,44,161₹2.85k Cr
2.07%85,47,299₹2.13k Cr
1.56%64,26,527₹1.60k Cr

FII / FPI

Foreign portfolio investors

9.45%1 named
HolderStakeSharesValue (₹ Cr)
1.29%53,22,821₹1.33k Cr

Mutual Funds

Domestic mutual funds & UTI

10.87%No names

No named holders ≥1% in this bucket.

DII (other)

Insurance, banks, AIF, other domestic institutions

4.52%No names

No named holders ≥1% in this bucket.

Retail & others

Holders below 1% disclosure threshold and public non-institutions

2.53%

SEBI requires naming only shareholders with ≥1% stake. The remaining 2.53% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.